Coverage by the News Media of the Benefits and Risks of Medications
Dennis Ross-Degnan
New England Journal of Medicine, 2000
View PDFchevron_right
Public engagement and the role of the media in post-marketing drug safety
Jonathan Gabe
Routledge eBooks, 2020
View PDFchevron_right
Lay media reporting of rosiglitazone risk: extent, messaging and quality of reporting
Adriane Lewin, Garielle Brown
Cardiovascular Diabetology, 2009
View PDFchevron_right
The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance
Brian Edwards
Drug Safety, 2015
View PDFchevron_right
Inconsistencies among European Union Pharmaceutical Regulator Safety Communications: A Cross-Country Comparison
Jérémie Lefèvre
PLoS ONE, 2014
View PDFchevron_right
Public engagement and the role of the media in post-marketing drug safety: the case of Eltroxin® (levothyroxine) in New Zealand
Jonathan Gabe
Critical Public Health, 2017
View PDFchevron_right
Coverage by the news media of the benefits and risks of medications| NOVA. The University of Newcastle's Digital Repository
Connie Mah
The New England Journal of Medicine, 2000
View PDFchevron_right
Drug Safety Issues Covered by Lay Media: A Cohort Study of Direct Healthcare Provider Communications Sent between 2001 and 2015 in The Netherlands
Peter Mol
Drug Safety
View PDFchevron_right
The Future of Risk Communication and the Role of the Pharmaceutical Industry
Sweta Chakraborty
View PDFchevron_right
Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs
Alan Cassels
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2003
View PDFchevron_right
Adherence of Pharmaceutical Advertisements in Medical Journals to FDA Guidelines and Content for Safe Prescribing
Salomeh Keyhani
PLoS ONE, 2011
View PDFchevron_right
Analysis of US Food and Drug Administration Warning Letters
Stephen Glasser
Pharmaceutical Medicine, 2008
View PDFchevron_right
Medicines and the media: news reports of medicines recommended for government reimbursement in Australia
David A Newby
BMC Public Health, 2013
View PDFchevron_right
Public Perceptions of the Pharmaceutical Industry and Drug Safety
Matthew Whalen
Drug Safety, 2009
View PDFchevron_right
The Food and Drug Administration's Evolving Regulation of Press Releases
Nathan Cortez
View PDFchevron_right
Media coverage of cancer therapeutics: A review of literature
Richard Sullivan
Journal of Cancer Policy, 2023
View PDFchevron_right
Medication safety: opening up the black box
Barbara Mintzes
BMJ Quality & Safety, 2013
View PDFchevron_right
The Critical Role of Communication in Drug Safety
Bruce Hugman
2006
View PDFchevron_right
The Challenge of Effectively Communicating Risk-Benefit Information
Bruce Hugman
Drug Safety, 1997
View PDFchevron_right
Analysis of Australian newspaper coverage of medication errors
Reece Hinchcliff, David Greenfield
International Journal for Quality in Health Care, 2012
View PDFchevron_right
Communication on Safety of Medicines in Europe: Current Practices and General Practitioners' Awareness and Preferences
Peter Mol
Drug safety, 2017
View PDFchevron_right
Focusing on Risk Communication About Medicines
Mira Harrison-Woolrych
Drug Safety, 2012
View PDFchevron_right
A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States ‐ 2007 to 2016
Barbara Mintzes
Pharmacoepidemiology and Drug Safety, 2020
View PDFchevron_right
Drugs in the News How well do Canadian newspapers report the good, the bad and the ugly of new prescription drugs?
James McCormack
View PDFchevron_right
Impact of literature reports on drug safety signals
Maciej Szewczyk
Wiener klinische Wochenschrift, 2020
View PDFchevron_right